Compare IRTC & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | MMS |
|---|---|---|
| Founded | 2006 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.2B |
| IPO Year | 2016 | 1997 |
| Metric | IRTC | MMS |
|---|---|---|
| Price | $118.89 | $54.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $197.92 | N/A |
| AVG Volume (30 Days) | 519.0K | ★ 591.7K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.02% |
| EPS Growth | ★ 61.71 | 10.42 |
| EPS | N/A | ★ 3.50 |
| Revenue | $747,138,000.00 | ★ $2,392,236,000.00 |
| Revenue This Year | $19.60 | $0.44 |
| Revenue Next Year | $15.94 | $5.15 |
| P/E Ratio | ★ N/A | $15.73 |
| Revenue Growth | ★ 26.24 | N/A |
| 52 Week Low | $100.85 | $53.40 |
| 52 Week High | $210.01 | $100.00 |
| Indicator | IRTC | MMS |
|---|---|---|
| Relative Strength Index (RSI) | 59.07 | 32.58 |
| Support Level | $111.37 | N/A |
| Resistance Level | $121.88 | $63.26 |
| Average True Range (ATR) | 5.56 | 2.01 |
| MACD | 1.26 | -0.49 |
| Stochastic Oscillator | 85.36 | 11.46 |
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.